# Hydrosorb® Versus Control in the Management of Radio-induced Skin Toxicity: Multicentre Controlled Phase III Randomized Trial

> **NCT02839473** · PHASE3 · COMPLETED · sponsor: **Institut Curie** · enrollment: 278 (actual)

## Conditions studied

- Breast Cancer
- Radiation Dermatitis

## Interventions

- **DEVICE:** Castalie water spray
- **DEVICE:** Hydrogel Hydrosorb®

## Key facts

- **NCT ID:** NCT02839473
- **Lead sponsor:** Institut Curie
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 278 (ACTUAL)
- **Last updated:** 2025-09-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02839473

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02839473, "Hydrosorb® Versus Control in the Management of Radio-induced Skin Toxicity: Multicentre Controlled Phase III Randomized Trial". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02839473. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*